Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Cheminet

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|June 13, 2023
[Sickle cell disease: from a pediatric disease to an adult disease]Bérengère Koehl, Geoffrey Cheminet
La Revue Du Praticien|June 2, 2026
[Prolonged fever: specific situations that alter the diagnostic approach]Geoffrey Cheminet, Adrien Michon, Jean-Benoît Arlet
European Journal of Haematology|August 9, 2023
Response to "Efficacy of COVID-19 vaccination in adult patients with sickle cell disease: Comment"Geoffrey Cheminet, Julien Derdevet, Jean-Benoît Arlet
La Revue Du Praticien|June 2, 2026
[Prolonged fever]Geoffrey Cheminet, Adrien Michon, Jean-Benoît Arlet
La Revue De Medecine Interne|August 13, 2025
[How to manage hypomagnesemia?]Geoffrey Cheminet, Aude Ritter, Pascal Houillier, et al.
Presse Medicale (Paris, France : 1983)|November 8, 2023
Sickle cell disease and pregnancyJulie Carrara, Anoosha Habibi, Alexandra Benachi, et al.
La Revue De Medecine Interne|January 8, 2025
[Extramedullary hematopoiesis, a rare complication of sickle cell disease: A six-case series and literature review]Ugo Boccadifuoco, Geoffrey Cheminet, Benjamin Morino, et al.
The Journal of Infection|August 21, 2019
Diagnostic accuracy of 16S rDNA PCR in bacterial pyomyositis: A prospective studyThomas Gabas, Isabelle Podglajen, Geoffrey Cheminet, et al.
The Journal of Antimicrobial Chemotherapy|January 26, 2023
Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltrationSalomé Abdellaoui, Matthieu Gregoire, Marie Dubert, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2022
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19Emmanuel Lafont, Hélène Pere, David Lebeaux, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|June 13, 2023
[Sickle cell disease: from a pediatric disease to an adult disease]Bérengère Koehl, Geoffrey Cheminet
La Revue Du Praticien|June 2, 2026
[Prolonged fever: specific situations that alter the diagnostic approach]Geoffrey Cheminet, Adrien Michon, Jean-Benoît Arlet
European Journal of Haematology|August 9, 2023
Response to "Efficacy of COVID-19 vaccination in adult patients with sickle cell disease: Comment"Geoffrey Cheminet, Julien Derdevet, Jean-Benoît Arlet
La Revue Du Praticien|June 2, 2026
[Prolonged fever]Geoffrey Cheminet, Adrien Michon, Jean-Benoît Arlet
La Revue De Medecine Interne|August 13, 2025
[How to manage hypomagnesemia?]Geoffrey Cheminet, Aude Ritter, Pascal Houillier, et al.
Presse Medicale (Paris, France : 1983)|November 8, 2023
Sickle cell disease and pregnancyJulie Carrara, Anoosha Habibi, Alexandra Benachi, et al.
La Revue De Medecine Interne|January 8, 2025
[Extramedullary hematopoiesis, a rare complication of sickle cell disease: A six-case series and literature review]Ugo Boccadifuoco, Geoffrey Cheminet, Benjamin Morino, et al.
The Journal of Infection|August 21, 2019
Diagnostic accuracy of 16S rDNA PCR in bacterial pyomyositis: A prospective studyThomas Gabas, Isabelle Podglajen, Geoffrey Cheminet, et al.
The Journal of Antimicrobial Chemotherapy|January 26, 2023
Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltrationSalomé Abdellaoui, Matthieu Gregoire, Marie Dubert, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2022
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19Emmanuel Lafont, Hélène Pere, David Lebeaux, et al.
Pageof 3